Lawrence Parish, MD
Dermatology · Philadelphia, PANPI 1548259815
Payments from drug & device makers
Across 678 payments — averaging $4273.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$939K
- Eli Lilly$485K
- Janssen Research & Development, LLC$416K
- UCB SA$377K
- GSK$184K
- AbbVie$138K
- plus $358K from 12 others
Across 25 payments — averaging $4656.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glenmark Pharmaceuticals Inc., USA$116K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $938,856 |
| Eli Lilly | 20 | $485,091 |
| Janssen Research & Development, LLC | 246 | $416,349 |
| UCB SA | 106 | $376,894 |
| GSK | 25 | $184,034 |
| AbbVie | 89 | $138,284 |
| Dr.reddy's Laboratories,inc. | 30 | $78,364 |
| Bristol Myers Squibb | 9 | $74,055 |
| Incyte Corporation | 47 | $70,925 |
| Pfizer | 31 | $57,425 |
| Galderma Laboratories, L.p. | 13 | $42,541 |
| Sanofi US Services Inc. | 1 | $13,000 |
| Boehringer Ingelheim | 3 | $8,727 |
| Vanda Pharmaceuticals Inc. | 2 | $6,250 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $4,206 |
| UCB Biosciences Inc. | 18 | $2,082 |
| Johnson & Johnson | 1 | $80 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,897,176 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Philadelphia
- Victoria WerthPhiladelphia$7.2M
- Joel GelfandPhiladelphia$3.6M
- Stephen HessPhiladelphia$1.7M
- Susan TaylorPhiladelphia$939K
- Jennifer ParishPhiladelphia$926K
- Nicholas MollanazarPhiladelphia$509K
- Zelma Chiesa FuxenchPhiladelphia$396K
- Katrina AbuabaraPhiladelphia$359K
- Joy WanPhiladelphia$358K
- Harold FarberPhiladelphia$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.